WHO/EDM/QSM/2004.4 ENGLISH ONLY

WORLD HEALTH ORGANIZATION

ORGANISATION MONDIALE DE LA SANTE

INDEX OF PHARMACOPOEIAS

The data presented in this list have been provided by national pharmacopoeia commissions. The list is provided for reference purposes only and does not pretend to be complete.

In order to bring this list up to date we would appreciate any additional data you may have. Please address your observations to Quality Assurance & Safety: Medicines, Essential Drugs and other Medicines, World Health Organization, 1211 Geneva 27, Switzerland, Fax: (0041 22) 791 47 30, or e-mail: [email protected].

Index of pharmacopoeias © World Health Organization 2004 All rights reserved. WHO/EDM/QSM/2004.4 page 2

1. NATIONAL

COUNTRY TITLE 1. PHARMACOPOEIA COMMISSIONS EDITION YEAR LANGUAGE 2. PUBLISHER/DISTRIBUTOR ______

Argentina 1. & 2. Farmacopea Argentina 6th Edition 1978 Spanish Av. Caseros 2161, (1264) Capital Federal Buenos Aires, Argentina

______

Austria 1. Arzneibuch Kommission, Bundesministerium für Gesundheit und Konsumenten Schutz Sektion Gesundheitswesen Radetzky Strasse 2, A-1031 Wien

Österreichisches Arzneibuch 2. Verlag der Österreichischen Staatsdruckerei, Official Edition 1990 German Rennweg 12a, A-1030 Wien Addendum 1 1990 German Addendum 2 1991 German ______

Brazil 1. Comissão Permanente de Revisão de Farmacopéia Brasileira Prédio 21 – Sala 5013 Caixa Postal 5083 CEP 97111-970 Santa Maria RS

Farmacopéia Brasileira 2. Atheneu Editora - São Paolo Ltda. 4th Edition Part 1 1988 Portuguese 4th Edition Part 2, vol.1 1996 Portuguese 4th Edition Part 2, vol.2 2000 Portuguese 4th Edition Part 2, vol.3 2002 Portuguese

1. see above

Brazilian Homeopathic 2. Organizações Andrei Editora S.A. 2nd Edition, Part 1 1997 Portuguese Pharmacopoeia Editora Atheneu Saõ Paolo Ltda.

______

China 1. State Pharmacopoeia Commission WHO/EDM/QSM/2004.4 page 3

Building 11 Fahua Nan li, Chongwen District, 100061 Beijing

Pharmacopoeia of the People's 2. Chemical Industry Press Volumes 1 & 2 2000 Chinese Republic of China 3, Huixinli, Chaoyang District, Beijing 100029 English ______

Croatia 1. Pharmacopoeia Commission, Institute of the Control of Drugs M. Pijade 160, 41000 Zagreb ______

Czech Republic 1. Czech Pharmacopoeia Commission Ministry of Health State Institute for Drug Control Šrobárova 48, 100-41 Prague 10, Czech Republic

Český lékopis, 2. Vydala Grada Publishing a.s. Volumes 1-5 2002 Czech Pharmacopoea Bohemica U Pruhonu 466/22, Praha 7-Holešovice, MMII Jako svou 1739. publikaci

The Czech Pharmacopoeia ______

Denmark 1. Danish Pharmacopoeia Commission Danish Medicines Agency Frederikssundsvej 378 DK-2700 Brønshøj ______

Egypt 1. Permanent Commission of the Egyptian Pharmacopoeia, Faculty of Pharmacy, Kasr El Ainy, Cairo

Egyptian Pharmacopoeia 2. General Organization for Government Printing III 1984 Arabic Office, Cairo English ______WHO/EDM/QSM/2004.4 page 4

Finland 1. Finnish Pharmacopoeia Committee Laakelaitos, National Agency for Medicines P.O. Box 55, Mannerheimintie 166 FIN-00301 Helsinki ______

France Pharmacopée française 1. Commission Nationale de la Pharmacopée X Française, Agence Française de Sécurité Sanitaire 2002 French des Produits de Santé–Direction des Laboratoires et des Contrôles, Unité Pharmacopée, 143-147, Boulevard Anatole France, F-93285 Saint-Denis

2. Groupe Liaisons SA 1, Avenue Edouard Belin 92856 Rueil – Malmaison Cedex ______

Germany 1. Deutsche Arzneibuch-Kommission, Bundesinstitut für Arzneimittel und Medizinprodukte Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn

Deutsches Arzneibuch 2. Deutscher Apotheker Verlag, Stuttgart 2002 German Govi-Verlag- Pharmazeutischer Verlag GmbH, Eschborn

1. Deutsche Homöopathische Arzneibuch- Kommission Bundesinstitut für Arzneimittel und Medizinprodukte Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn

Homöopathisches Arzneibuch 2. Deutscher Apotheker Verlag, Stuttgart 2002 German Govi-Verlag- Pharmazeutischer Verlag GmbH, Eschborn ______WHO/EDM/QSM/2004.4 page 5

Greece 1. Greek Pharmacopoeia Commission

Greek Pharmacopoeia 2. EOF, National Organisation for Medicines, V, vol. 2 1998 Greek ELLINIKI PHARMACOPOIIA Mesogeion Street, 284 1st Supplement 2000 Greek 15562 Holargos Attikis 2nd Supplement 2002 Greek Greece ______

Hungary 1. Hungarian Pharmacopoeia Commission (OGYI) National Institute of Pharmacy, P.O.B. 450 H-1372 Budapest 5

Pharmacopoea Hungarica 2. Medicina konyvkiado, Budapest VII 1986 Hungarian

______

India 1. Indian Pharmacopoeia Committee Ministry of Health and Family Welfare Government of India New Delhi-110011

Indian Pharmacopoeia 2. The Controller of Publications, Delhi IP 1996 1996 English Civil Lines, Addendum 2000 2000 English Delhi-110 054 Addendum 2002 2002 English

______

Indonesia 1. Indonesian Pharmacopoeia Commission, Direktorat Jenderal Pengawasan Obat Dan Makanan Departemen Kesehatan R.I., Djl, Percetakan Negara 23, Jakarta

Farmakope Indonesia 2. Departemen Kesehatan Republik Indonesia IV 1995 Indonesian DJL. Percetakan Negara 23 Jakarta ______WHO/EDM/QSM/2004.4 page 6

Iran Iranian Pharmacopoeia 1. Iranian Pharmacopoeia Drug Administration of Iran, Division of Pharmaceuticals & Narcotic Affairs Fakhre- Razi Street Ministry of Health of Iran Building Tehran, 14, Iran ______

Italy 1. Permanent Commission of the Italian Pharmacopoeia, Istituto Superiore di Sanità, Viale Regina Elena 299, I-00161 Roma

Farmacopea Ufficiale della 2. Ministerio della Salute,Commissione Xl 2002 Italian Repubblica Italiana permanente per la revisione e pubblicazione della Farmacopea Ufficiale, Istituto Poligrafico e Zecca dello Stato P. V., 1213045 Roma ______

Japan 1. Committee of the Japanese Pharmacopoeia Evaluation & Licensing Division Pharmaceuticals & Food Safety Bureau Ministry of Health, Labour and Welfare, 1-2-2, Kasumigaseki Chiyoda-ku, Tokyo 100-8916

The Japanese Pharmacopoeia 2. Ministry of Health, Labour and Welfare, XIV 2001 Japanese 1-2-2, Kasumigaseki English Chiyoda-ku, Tokyo 100-8916

______

Korea 1. Central Pharmaceutical Affairs Council 5, Nokbun-Dong, Eunpyung-ku, Seoul 122-704 Korea

The Korean Pharmacopoeia 2. Korea Food and Drug Administration VIII 2002 Korean 5, Nokbun-Dong, Eunpyung-ku, Seoul English 122-704 Korea ______

WHO/EDM/QSM/2004.4 page 7

Lithuania 1. Lithuanian Pharmacopoeial Committee Traku St. 14 Vilnius 2024

______

Mexico 1. Comisión Permanente de la Farmacopea de los Estados Unidos Mexicanos, Dr Balmis 148, Unidad Medicina Experimental de la UNAM, 2° piso, Col Doctores, C.P. 06726 Hospital General de México, México DF

Farmacopea de los Estados 2. Secretaría de Salud, VII 2000 Spanish Unidos Mexicanos Monterrey 33, Col. Roma, Supplement 1 2001 Spanish C.P. 06700, México DF Supplement 2 2002 Spanish

Mexican Herbal Pharmacopoeia 1st Edition, 2001 Spanish

Mexican Homeopathic 1st Edition 1998 Spanish Pharmacopoeia ______

Norway 1. Norwegian Pharmacopoeia Commission, Statens Legemiddelverk, Sven Oftedals Vei 6, N-0950 Oslo ______

Pakistan 1. Pakistan Pharmacopoeia Commission, Ministry of Health, Special Education & Social Welfare, Islamabad ______

Poland 1. Polish Pharmacopoeia Commission, Office for Registration of Medicinal Products, Medical Devices & Biocides Chelmska Street 30-34, PL-00-725 Warsaw

Farmakopea Polska 2. Polish Pharmaceutical Society VI 2002 Polish Dluga str. 16, PL-00-238 Warsaw

______WHO/EDM/QSM/2004.4 page 8

Portugal 1. Comisão Permanente da Farmacopeia Portuguesa, Faculdade de Farmácia, Rua Aníbal Cunha, P-4000 Porto

Farmacopeia Portuguesa 2. Impresa Nacional, Casa da Moeda, VI 1997 Portuguese Lisboa Supplement 2000 Portuguese ______

Romania 1. Romanian Pharmacopoeia Commission Aviator Sanatescu 48, R-71324 Bucuresti

Farmacopeea Romana 2. Editura Medicala- Bucuresti A X-A 1993 Romanian Supplement 2000 Romanian ______

Russian Federation 1. Pharmacopoeia Committee, Ministry of Health, Rahmanovskij Per. 3, 101431 GSP Moskva K-51

State Pharmacopoeia of the 2. Medicina, XI Vol.1 1987 Russian Union of Soviet Socialist Petroverigskiy Pereulok 6/8, 101000 Moscow Vol.2 1990 Russian Republics ______

Slovakia 1. Slovak Pharmacopoeia Commission/ Slovenská liekopisna Komisia State Institute for the Drug Control Kvetna 11, 825 08 Bratislava

Pharmacopoea Slovaca 2. Ministerstvo zdravotníctva, l, volume l 1997 Slovak Slovenský liekopis Vydavatel’stvo Herba spol. s r.o. l, volume ll 1999 Slovak Bratislava l, volume lll 2000 Slovak I, volume IV 2001 Slovak I, volume V 2002 Slovak

______WHO/EDM/QSM/2004.4 page 9

Slovenia 1. Pharmacopoeia Commission Agency for Medicinal Products, Kersnikova 2, SI-1000 Ljubljana Slovenia ______

Spain 1. Ministerio de Sanidad y Consumo Agencia española del medicamento Secretaría técnica de la Real Farmacopea Española Po. del Prado 18-20, 28014 Madrid

Real Farmacopea Española 2. Ministerio de Sanidad y Consumo 2nd edition 2002 Spanish Secretaría General Técnica Supplement 2.1 2002 Spanish Centro de Publicaciones and Supplement 2.2 2003 Spanish La Librería del BOE Trafalgar, 27. 28010 Madrid ______

Sweden 1. Swedish Pharmacopoeia Commission, Medical Products Agency P.O. Box 26 S-751 03 Uppsala ______

Switzerland 1. Commission Suisse de Pharmacopée Swissmedic, Institut suisse des produits thérapeutiques, Service Pharmacopée, Erlachstrasse 8, 3000 Berne 9

Pharmacopoea Helvetica 2. Office fédéral des constructions et de la logistique IX 2003 French Fellerstrasse 21, CH-3003 Bern German Italian Supplement 9.1 2003 French German Italian Supplement 9.2 2003 French German Italian ______

WHO/EDM/QSM/2004.4 page 10

Thailand Thai Pharmacopoeia 1. Thai Pharmacopoeia Committee Department of Medical Sciences Ministry of Public Health Tiwanond Road, Nonthaburi 11000, Thailand

2. Thai Pharmacopoeia and Reference Substance 1st Edition Section Vol. I Part 1 1987 English Bureau of Drug and Narcotics Vol. I Part 2 1993 English Department of Medical Sciences Vol. II Part 1 1997 English Ministry of Public Health Vol. II Part 2 2000 English Tiwanond Road, Nonthaburi 11000, Thailand Vol. II Part 3 2003 English

Thai Herbal Pharmacopoeia 1. & 2. as above Volume I 1995 English Volume II 2000 ______

Turkey 1. Commission of the Turkish Pharmacopoeia Ministry of Health, Saglik Bakanligi Ilac Komisyonu, Sihhiye, TR-06434 Ankara

______

Ukraine 1. Scientific and Expert Pharmacopoeial Center (Pharmacopoeial Center) State Department for Control of the Quality , Safety And Manufacture of Pharmaceuticals and Medicinal Goods Ministry of Health of Ukraine Astronomicheskaya st. 33 61085 Kharkov, Ukraine

The State Pharmacopoeia of the 2. 1st edition 2001 Ukrainian Ukraine Publisher: “RIREG”, Kharkov Distributor: Pharmacopoeial Center, Astronomicheskaya st. 33 61085 Kharkov, Ukraine ______WHO/EDM/QSM/2004.4 page 11

United Kingdom 1. British Pharmacopoeia Commission, Market Towers, 1 Nine Elms Lane, London SW8 5NQ

British Pharmacopoeia 2. The Stationery Office, 2003 English London ______

United States The United States Pharmacopeia 1. & 2. The United States Pharmacopeia USP 27, NF 22 2004 English of America The National Formulary 12601 Twinbrook Parkway, Rockville, MD 20852 Supplement 1 2004 English

______

Vietnam Pharmacopoeia Vietnamica 1. & 2. Vietnamese Pharmacopoeia Commission 3rd edition 2002 Vietnamese Ministry of Health – S.R. Vietnam 48 Hai Ba Trung, Hanoi, Vietnam ______

Yugoslavia Pharmacopoea Jugoslavica 1. Izdanje Saveznog zavoda za IV 1984 Serbo- zdravstvenu zastitu, Belgrade Croatian ______

WHO/EDM/QSM/2004.4 page 12

2. REGIONAL AND SUBREGIONAL

______

Europe European Pharmacopoeia 1. & 2. European Directorate for the Quality of 4th edition 2002 English/French Medicines, Council of Europe, - 226 Avenue de Supplement 4.1 2002 English/French Colmar B.P. 907, Supplement 4.2 2002 English/French F-67029 Strasbourg Cedex 1, France Supplement 4.3 2003 English/French Supplement 4.4 2003 English/French Supplement 4.5 2003 English/French Supplement 4.6 2004 English/French Supplement 4.7 2004 English/French

The European Pharmacopoeia Convention has been signed and is applied by: Austria, Belgium, Bosnia-Herzegovina, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Netherlands, Norway, Portugal, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, The former Yugoslav Republic of Macedonia, Turkey, United Kingdom, Federal Republic of Yugoslavia and the European Union.

______

Africa African Pharmacopoeia 2. OAU/STRC Publications Division 1 1985 English PMB 2359, Lagos, Nigeria 2 1986 English

______

WHO/EDM/QSM/2004.4 page 13

3. INTERNATIONAL

______

WHO, Geneva 1. WHO Expert Committee on Specifications for Pharmaceutical Preparations

The International Pharmacopoeia 2. Marketing and Dissemination III, Vol.1 1979 English World Health Organization, 1980 French 1211 Geneva 27, Switzerland 1980 Spanish FAX (41-22) 791 48 57 1981 Russian e-mail [email protected]

Vol. 2 1981 English 1981 French 1983 Spanish 1983 Russian

Vol. 3 1988 English 1988 French 1989 Spanish 1990 Russian

Vol. 4 1994 English 1994 French 1996 Spanish 1995 Russian

Vol. 5 2003 English ______

* * *